InteRNA Technologies Receives Notice of Allowance for miRNA Sequences of its Lead Pre-Clinical Product

News   Oct 15, 2012

 
InteRNA Technologies Receives Notice of Allowance for miRNA Sequences of its Lead Pre-Clinical Product
 
 
 
 

RELATED ARTICLES

Potential Barcode Identified for a Form of Alcoholic Liver Disease

News

NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.

READ MORE

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

RNA Molecules Lives Are 10 Times Shorter Than Previously Thought

News

A research group at the Biozentrum of the University of Basel has developed a new method to measure the half-life of RNA molecules.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE